113 related articles for article (PubMed ID: 3555512)
1. Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay.
Zeiler HJ; Petersen U; Gau W; Ploschke HJ
Arzneimittelforschung; 1987 Feb; 37(2):131-4. PubMed ID: 3555512
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
Galante D; Pennucci C; Esposito S; Barba D
Drugs Exp Clin Res; 1985; 11(5):331-4. PubMed ID: 2941260
[TBL] [Abstract][Full Text] [Related]
3. Transfer of ciprofloxacin to bile and determination of biliary metabolites in humans.
Tanimura H; Tominaga S; Rai F; Matsumoto H
Arzneimittelforschung; 1986 Sep; 36(9):1417-20. PubMed ID: 3790196
[TBL] [Abstract][Full Text] [Related]
4. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
Fromtling RA; Abruzzo GK; Gadebusch HH
Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
[TBL] [Abstract][Full Text] [Related]
5. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
Vuye A
Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
[TBL] [Abstract][Full Text] [Related]
6. Overview of Scandinavian in vitro studies with ciprofloxacin.
Forsgren A
Scand J Infect Dis Suppl; 1989; 60():16-22. PubMed ID: 2667106
[TBL] [Abstract][Full Text] [Related]
7. Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.
Zeiler HJ
Drugs Exp Clin Res; 1985; 11(5):335-8. PubMed ID: 2941261
[TBL] [Abstract][Full Text] [Related]
8. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Piccolomini R; Allocati N; Catamo G
Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
[TBL] [Abstract][Full Text] [Related]
9. Experience with ciprofloxacin in vitro and in vivo.
Giamarellou H; Efstratiou A; Tsagarakis J; Petrikkos G; Daikos GK
Arzneimittelforschung; 1984; 34(12):1775-8. PubMed ID: 6442151
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria.
Vila J; Sánchez-Céspedes J; Sierra JM; Piqueras M; Nicolás E; Freixas J; Giralt E
Int J Antimicrob Agents; 2006 Jul; 28(1):19-24. PubMed ID: 16781123
[TBL] [Abstract][Full Text] [Related]
11. In vitro antibacterial activity of irloxacin (E-3432) on clinical isolates.
Coll R; Esteve M; Moros M; Xicota MA; Parés J
Drugs Exp Clin Res; 1987; 13(2):75-7. PubMed ID: 3582134
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
[TBL] [Abstract][Full Text] [Related]
13. [Studies on pyridonecarboxylic acids as antibacterial agents. XII. Synthesis and antibacterial activity of 6-chloro-1-cyclopropyl-7-(1-piperazinyl)-1, 4-dihydro-4-oxo-quinoline-3-carboxylic acid and analogues].
Li XH; Tian ZM; Miao H; Yu LX; Guo HY
Yao Xue Xue Bao; 1997 Nov; 32(11):844-51. PubMed ID: 11596203
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial activity of ciprofloxacin in the urine during four days after a single 500 mg and 750 mg oral dose].
Guibert J; Kitzis MD; Acar JF
Pathol Biol (Paris); 1994 Jun; 42(6):587-92. PubMed ID: 7854859
[TBL] [Abstract][Full Text] [Related]
15. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
Muytjens HL; van der Ros-van de Repe J; van Veldhuizen G
Antimicrob Agents Chemother; 1983 Aug; 24(2):302-4. PubMed ID: 6227281
[TBL] [Abstract][Full Text] [Related]
16. Comparative quantification of the in vitro activity of veterinary fluoroquinolones.
Grobbel M; Lübke-Becker A; Wieler LH; Froyman R; Friederichs S; Filios S
Vet Microbiol; 2007 Sep; 124(1-2):73-81. PubMed ID: 17498893
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activity of E-3604, a new 6-fluoroquinolone, on clinical isolates.
Xicota MA; Coll R; Esteve M; Moros M; Parés J
Drugs Exp Clin Res; 1987; 13(3):133-6. PubMed ID: 3622242
[TBL] [Abstract][Full Text] [Related]
19. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
Piccolomini R; Ravagnan G
Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis and antibacterial activity of N-(aroylalkyl) ciprofloxacin].
Hu AX; Wang YT; You TB
Yao Xue Xue Bao; 2007 Aug; 42(8):854-7. PubMed ID: 17944234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
